Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 55.7B | 59.0B | 56.5B | 60.6B |
| Cost of revenue | 47.4B | 48.2B | 50.7B | 51.1B |
| Gross profit | 8.3B | 10.8B | 5.8B | 9.5B |
| Operating expense | ||||
| Research & development | 236.9M | 157.7M | 282.1M | 250.5M |
| Selling general and admin | 2.6B | 2.4B | 2.8B | 2.7B |
| Other operating expenses | 306.8M | 179.0M | 732.9M | 259.9M |
| Operating income | 5.1B | 8.1B | 2.1B | 6.3B |
| Non operating interest income | ||||
| Income | 512.2M | 482.3M | 157.7M | 663.0M |
| Expense | 916.1M | 954.5M | 1.1B | 1.0B |
| Other income expense | — | — | — | — |
| Pretax income | 5.1B | 7.6B | 3.6B | 6.2B |
| Tax provision | 2.0B | 3.5B | 2.7B | 2.5B |
| Net income | 3.1B | 4.2B | 887.1M | 3.7B |
| Basic EPS | — | 1.6 | 0.3 | 1.4 |
| Diluted EPS | — | 1.6 | 0.3 | 1.4 |
| Basic average shares | — | 2.6B | 2.6B | 2.7B |
| Diluted average shares | — | 2.6B | 2.6B | 2.7B |
| EBITDA | 10.6B | 13.3B | 7.7B | 12.4B |
| Net income from continuing op. | 5.1B | 7.6B | 3.6B | 6.2B |
| Minority interests | -36.6M | -81.0M | -96.3M | -85.2M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |